Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Magenta, Alessandra ^a   Greco, Simona ^b   Capogrossi, Maurizio C ^a   Gaetano, Carlo ^c   Martelli, Fabio ^b  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; MICRORNA; NITRIC OXIDE; PROTEIN P66; PROTEIN SHC; REACTIVE OXYGEN METABOLITE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; INSULIN; SHC1 PROTEIN, HUMAN;

AGING; ARTICLE; DIABETIC ANGIOPATHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; EPIGENETICS; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; INSULIN RESISTANCE; NONHUMAN; OXIDATIVE STRESS; ANIMAL; CHEMISTRY; DIABETES MELLITUS; GENETIC EPIGENESIS; METABOLISM; MOUSE; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

AGING; ANIMALS; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; EPIGENESIS, GENETIC; HUMANS; HYDROGEN PEROXIDE; HYPERCHOLESTEROLEMIA; INSULIN; INSULIN RESISTANCE; MICE; MICRORNAS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION; VASCULAR DISEASES;

EID: 84897898253     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/193095     Document Type: Article

References (155)

1. Deanfield J. E., Halcox J. P., Rabelink T. J., Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007 115 10 1285 1295 2-s2.0-33947716172 10.1161/CIRCULATIONAHA.106.652859 (Pubitemid 46594773)
2. Napoli C., Ignarro L. J., Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Archives of Pharmacal Research 2009 32 8 1103 1108 2-s2.0-69949111623 10.1007/s12272-009-1801-1
3. Magenta A., Greco S., Gaetano C., Oxidative stress and microRNAs in vascular diseases. International Journal of Molecular Sciences 2013 14 9 17319 17346
4. Gutterman D. D., Miura H., Liu Y., Redox modulation of vascular tone: focus of potassium channel mechanisms of dilation. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 4 671 678 2-s2.0-16244365903 10.1161/01.ATV. 0000158497.09626.3b (Pubitemid 40463852)
5. Miki H., Funato Y., Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species. Journal of Biochemistry 2012 151 3 255 261 2-s2.0-84858218213 10.1093/jb/mvs006
6. Yang Y., Huang A., Kaley G., Sun D., eNOS uncoupling and endothelial dysfunction in aged vessels. American Journal of Physiology-Heart and Circulatory Physiology 2009 297 5 H1829 H1836 2-s2.0-70350459448 10.1152/ajpheart.00230.2009
7. Higashi Y., Noma K., Yoshizumi M., Kihara Y., Endothelial function and oxidative stress in cardiovascular diseases. Circulation Journal 2009 73 3 411 418 2-s2.0-62649123264 10.1253/circj.CJ-08-1102
8. Ray P. D., Huang B., Tsuji Y., Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cellular Signalling 2012 24 5 981 990 2-s2.0-84857116578 10.1016/j.cellsig.2012.01.008
9. Cooper M. E., El-Osta A., Epigenetics: mechanisms and implications for diabetic complications. Circulation Research 2010 107 12 1403 1413 2-s2.0-78650694320 10.1161/CIRCRESAHA.110.223552
10. Giorgio M., Trinei M., Migliaccio E., Pelicci P. G., Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nature Reviews Molecular Cell Biology 2007 8 9 722 728 2-s2.0-34548148201 10.1038/nrm2240 (Pubitemid 47312827)
11. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
12. Huntzinger E., Izaurralde E., Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nature Reviews Genetics 2011 12 2 99 110 2-s2.0-78751477191 10.1038/nrg2936
13. Guay C., Roggli E., Nesca V., Jacovetti C., Regazzi R., Diabetes mellitus, a microRNA-related disease? Translational Research 2011 157 4 253 264 2-s2.0-79952795269 10.1016/j.trsl.2011.01.009
14. Pandey A. K., Agarwal P., Kaur K., Datta M., MicroRNAs in diabetes: tiny players in big disease. Cellular Physiology and Biochemistry 2009 23 4-6 221 232 2-s2.0-66749146650 10.1159/000218169
15. van de Bunt M., Gaulton K. J., Parts L., The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS ONE 2013 8 1 e55272
16. Muniyappa R., Quon M. J., Insulin action and insulin resistance in vascular endothelium. Current Opinion in Clinical Nutrition and Metabolic Care 2007 10 4 523 530 2-s2.0-34250676461 10.1097/MCO.0b013e32819f8ecd (Pubitemid 46934125)
17. Ware J. A., Heistad D. D., Flier J., Salzman E., Weller P., Platelet-endothelium interactions. The New England Journal of Medicine 1993 328 9 628 635 2-s2.0-0027397638 10.1056/NEJM199303043280907 (Pubitemid 23065363)
18. Vincent M. A., Montagnani M., Quon M. J., Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Current Diabetes Reports 2003 3 4 279 288 2-s2.0-0141671792 (Pubitemid 38906783)
19. Federici M., Pandolfi A., de Filippis E. A., Pellegrini G., Menghini R., Lauro D., Cardellini M., Romano M., Sesti G., Lauro R., Consoli A., G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells. Circulation 2004 109 3 399 405 2-s2.0-9144222572 10.1161/01.CIR.0000109498.77895.6F (Pubitemid 38133910)
20. Duncan E. R., Crossey P. A., Walker S., Effect of endothelium-specific insulin resistance on endothelial function in vivo. Diabetes 2008 57 12 3307 3314
21. Jiang Z. Y., Lin Y., Clemont A., Feener E. P., Hein K. D., Igarashi M., Yamauchi T., White M. F., King G. L., Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. The Journal of Clinical Investigation 1999 104 4 447 457 2-s2.0-0032719024 (Pubitemid 29534329)
22. Nacci C., Tarquinio M., Montagnani M., Molecular and clinical aspects of endothelial dysfunction in diabetes. Internal and Emergency Medicine 2009 4 2 107 116 2-s2.0-62949133518 10.1007/s11739-009-0234-7
23. Wheatcroft S. B., Williams I. L., Shah A. M., Kearney M. T., Pathophysiological implications of insulin resistance on vascular endothelial function. Diabetic Medicine 2003 20 4 255 268 2-s2.0-0037900056 10.1046/j.1464-5491.2003.00869.x (Pubitemid 36606117)
24. Montagnani M., Golovchenko I., Kim I., Koh G. Y., Goalstone M. L., Mundhekar A. N., Johansen M., Kucik D. F., Quon M. J., Draznin B., Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. The Journal of Biological Chemistry 2002 277 3 1794 1799 2-s2.0-18544363627 10.1074/jbc.M103728200 (Pubitemid 34968751)
25. Stocker R., Keaney J. F. Jr., Role of oxidative modifications in atherosclerosis. Physiological Reviews 2004 84 4 1381 1478 2-s2.0-4644310560 10.1152/physrev.00047.2003 (Pubitemid 39302636)
26. San Martín A., Du P., Dikalova A., Lassègue B., Aleman M., Góngora M. C., Brown K., Joseph G., Harrison D. G., Taylor W. R., Jo H., Griendling K. K., Reactive oxygen species-selective regulation of aortic inflammatory gene expression in type 2 diabetes. American Journal of Physiology-Heart and Circulatory Physiology 2007 292 5 H2073 H2082 2-s2.0-34250858839 10.1152/ajpheart.00943.2006 (Pubitemid 47084581)
27. Gao L., Mann G. E., Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovascular Research 2009 82 1 9 20 2-s2.0-62349116866 10.1093/cvr/cvp031
28. Tabit C. E., Chung W. B., Hamburg N. M., Vita J. A., Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Reviews in Endocrine and Metabolic Disorders 2010 11 1 61 74 2-s2.0-77953393648 10.1007/s11154-010-9134-4
29. Rajagopalan S., Harrison D. G., Reversing endothelial dysfunction with ACE inhibitors: a new TREND? Circulation 1996 94 3 240 243 2-s2.0-0029838582 (Pubitemid 26266102)
30. Henriksen E. J., Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2007 293 3 R974 R980 2-s2.0-34548452026 10.1152/ajpregu.00147.2007 (Pubitemid 47358914)
31. Oak J., Cai H., Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes 2007 56 1 118 126 2-s2.0-33847073821 10.2337/db06-0288
32. Pieper G. M., Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. Journal of Cardiovascular Pharmacology 1997 29 1 8 15 2-s2.0-0031033321 10.1097/00005344-199701000-00002 (Pubitemid 27045168)
33. Alp N. J., Mussa S., Khoo J., Cai S., Guzik T., Jefferson A., Goh N., Rockett K. A., Channon K. M., Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. The Journal of Clinical Investigation 2003 112 5 725 735 2-s2.0-0141612000 10.1172/JCI200317786 (Pubitemid 38057713)
34. Tousoulis D., Papageorgiou N., Androulakis E., Paroutoglou K., Stefanadis C., Novel therapeutic strategies targeting vascular endothelium in essential hypertension. Expert Opinion on Investigational Drugs 2010 19 11 1395 1412 2-s2.0-77958466526 10.1517/13543784.2010.522989
35. Thomas S. R., Chen K., Keaney J. F. Jr., Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. The Journal of Biological Chemistry 2002 277 8 6017 6024 2-s2.0-0037155131 10.1074/jbc.M109107200 (Pubitemid 34968385)
36. Drummond G. R., Cai H., Davis M. E., Ramasamy S., Harrison D. G., Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circulation Research 2000 86 3 347 354 2-s2.0-0033952940 (Pubitemid 30108830)
37. Chen C., Druhan L. J., Varadharaj S., Chen Y., Zweier J. L., Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme. The Journal of Biological Chemistry 2008 283 40 27038 27047 2-s2.0-55249112287 10.1074/jbc.M802269200
38. Giacco F., Brownlee M., Oxidative stress and diabetic complications. Circulation Research 2010 107 9 1058 1070 2-s2.0-78349297565 10.1161/CIRCRESAHA.110.223545
39. Gonzalez C. D., Lee M., Marchetti P., Pietropaolo M., Towns R., Vaccaro M. I., Watada H., Wiley J. W., The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy 2011 7 1 2 11 2-s2.0-78650848689 10.4161/auto.7.1.13044
40. Houstis N., Rosen E. D., Lander E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006 440 7086 944 948 2-s2.0-33645860825 10.1038/nature04634
41. Li J., Ichikawa T., Janicki J. S., Cui T., Targeting the Nrf2 pathway against cardiovascular disease. Expert Opinion on Therapeutic Targets 2009 13 7 785 794 2-s2.0-67650453921 10.1517/14728220903025762
42. Cheng X., Siow R. C. M., Mann G. E., Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxidants and Redox Signaling 2011 14 3 469 487 2-s2.0-78650913154 10.1089/ars.2010.3283
43. Tan Y., Ichikawa T., Li J., Si Q., Yang H., Chen X., Goldblatt C. S., Meyer C. J., Li X., Cai L., Cui T., Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 2011 60 2 625 633 2-s2.0-79551575483 10.2337/db10-1164
44. Zhang J., Patel J. M., Li Y. D., Block E. R., Proinflammatory cytokines downregulate gene expression and activity of constitutive nitric oxide synthase in porcine pulmonary artery endothelial cells. Research Communications in Molecular Pathology and Pharmacology 1997 96 1 71 87 2-s2.0-0030963007
45. Libby P., Ridker P. M., Maseri A., Inflammation and atherosclerosis. Circulation 2002 105 9 1135 1143 2-s2.0-0037022910 10.1161/hc0902.104353 (Pubitemid 34212626)
46. Beckman J. A., Paneni F., Cosentino F., Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. European Heart Journal 2013 34 31 2444 2452
47. Keaney J. F. Jr., Massaro J. M., Larson M. G., Vasan R. S., Wilson P. W. F., Lipinska I., Corey D., Sutherland P., Vita J. A., Benjamin E. J., Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring study. Journal of the American College of Cardiology 2004 44 1 168 173 2-s2.0-3242760622 10.1016/j.jacc.2004.03.048 (Pubitemid 38968477)
48. Festa A., D'Agostino R. Jr., Howard G., Mykkänen L., Tracy R. P., Haffner S. M., Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 2000 102 1 42 47 2-s2.0-0034604248 (Pubitemid 30430551)
49. Pradhan A. D., Manson J. E., Rifai N., Buring J. E., Ridker P. M., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 2001 286 3 327 334 2-s2.0-0035908632 (Pubitemid 32656163)
50. Schulze M. B., Rimm E. B., Li T., Rifai N., Stampfer M. J., Hu F. B., C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care 2004 27 4 889 894 2-s2.0-1842538093 10.2337/diacare.27.4.889 (Pubitemid 38420210)
51. Duncan B. B., Schmidt M. I., Pankow J. S., Ballantyne C. M., Couper D., Vigo A., Hoogeveen R., Folsom A. R., Heiss G., Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003 52 7 1799 1805 2-s2.0-0038691972 (Pubitemid 36792473)
52. Read M. A., Whitley M. Z., Williams A. J., Collins T., NF- B and I B α: an inducible regulatory system in endothelial activation. Journal of Experimental Medicine 1994 179 2 503 512 2-s2.0-0028179224
53. de Alvaro C., Teruel T., Hernandez R., Lorenzo M., Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. The Journal of Biological Chemistry 2004 279 17 17070 17078 2-s2.0-2342428466 10.1074/jbc.M312021200 (Pubitemid 38560462)
54. Kim F., Pham M., Maloney E., Rizzo N. O., Morton G. J., Wisse B. E., Kirk E. A., Chait A., Schwartz M. W., Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 11 1982 1988 2-s2.0-55449100538 10.1161/ATVBAHA.108.169722
55. Bonfini L., Migliaccio E., Pelicci G., Lanfrancone L., Pelicci P. G., Not all Shc's roads lead to Ras. Trends in Biochemical Sciences 1996 21 7 257 261 2-s2.0-0030199613 10.1016/0968-0004(96)10033-5 (Pubitemid 26228276)
56. Pelicci G., Dente L., de Giuseppe A., Verducci-Galletti B., Giuli S., Mele S., Vetriani C., Giorgio M., Pandolfi P. P., Cesareni G., Pelicci P. G., A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. Oncogene 1996 13 3 633 641 2-s2.0-9444229890 (Pubitemid 26283860)
57. Sakai R., Henderson J. T., O'Bryan J. P., Elia A. J., Saxton T. M., Pawson T., The mammalian ShcB and ShcC phosphotyrosine docking proteins function in the maturation of sensory and sympathetic neurons. Neuron 2000 28 3 819 833 2-s2.0-0034520582 10.1016/S0896-6273(00)00156-2 (Pubitemid 32038074)
58. Migliaccio E., Mele S., Salcini A. E., Pelicci G., Lai K. V., Superti-Furga G., Pawson T., Di Fiore P. P., Lanfrancone L., Pelicci P. G., Opposite effects of the p52(shc)/p46(shc) and p66(shc) splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. The EMBO Journal 1997 16 4 706 716 2-s2.0-0031056755 10.1093/emboj/16.4.706 (Pubitemid 27089518)
59. Pelicci G., Lanfrancone L., Grignani F., McGlade J., Cavallo F., Forni G., Nicoletti I., Grignani F., Pawson T., Pelicci P. G., A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992 70 1 93 104 2-s2.0-0026777369 10.1016/0092-8674(92)90536-L
60. Wills M. K., Jones N., Teaching an old dogma new tricks: twenty years of Shc adaptor signalling. Biochemical Journal 2012 447 1 1 16
61. Migliaccio E., Giogio M., Mele S., Pelicci G., Reboldi P., Pandolfi P. P., Lanfrancone L., Pelicci P. G., The p66(shc) adaptor protein controls oxidative stress response and life span in mammals. Nature 1999 402 6759 309 313 2-s2.0-0033581704 10.1038/46311 (Pubitemid 129516269)
62. Skolnik E. Y., Batzer A., Li N., Lee C.-H., Lowenstein E., Mohammadi M., Margolis B., Schlessinger J., The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 1993 260 5116 1953 1955 2-s2.0-0027182367 (Pubitemid 23258278)
63. Aronheim A., Engelberg D., Li N., Ai-Alawi N., Schlessinger J., Karin M., Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 1994 78 6 949 961 2-s2.0-0027931640 10.1016/0092-8674(94)90271-2 (Pubitemid 24292324)
64. Ohmichi M., Matuoka K., Takenawa T., Saltiel A. R., Growth factors differentially stimulate the phosphorylation of Shc proteins and their association with Grb2 in PC-12 pheochromocytoma cells. The Journal of Biological Chemistry 1994 269 2 1143 1148 2-s2.0-0027954437 (Pubitemid 24032498)
65. El-Shemerly M. Y. M., Besser D., Nagasawa M., Nagamine Y., 12-O-tetradecanoylphorbol-13-acetate activates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells. The Journal of Biological Chemistry 1997 272 49 30599 30602 2-s2.0-0030662196 10.1074/jbc.272.49.30599 (Pubitemid 27527487)
66. Kao A. W., Waters S. B., Okada S., Pessin J. E., Insulin stimulates the phosphorylation of the 66- and 52-kilodalton Shc isoforms by distinct pathways. Endocrinology 1997 138 6 2474 2480 2-s2.0-0030998473 10.1210/en.138.6.2474 (Pubitemid 27215252)
67. Yang C. P., Horwitz S. B., Taxol mediates serine phosphorylation of the 66-kDa Shc isoform. Cancer Research 2000 60 18 5171 5178 2-s2.0-0034665140
68. Nemoto S., Finkel T., Redox regulation of forkhead proteins through a p 66 S h c -dependent signaling pathway. Science 2002 295 5564 2450 2452 2-s2.0-0037192473 10.1126/science.1069004 (Pubitemid 34270258)
69. Khanday F. A., Yamamori T., Mattagajasingh I., Zhang Z., Bugayenko A., Naqvi A., Santhanam L., Nabi N., Kasuno K., Day B. W., Irani K., Rac1 leads to phosphorylation-dependent increase in stability of the p 66 S h c adaptor protein: role in Rac1-induced oxidative stress. Molecular Biology of the Cell 2006 17 1 122 129 2-s2.0-30044449425 10.1091/mbc.E05-06-0570 (Pubitemid 43049467)
70. Pinton P., Rimessi A., Marchi S., Orsini F., Migliaccio E., Giorgio M., Contursi C., Minucci S., Mantovani F., Wieckowski M. R., Del Sal G., Pelicci P. G., Rizzuto R., Protein kinase C β and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p 66 S h c. Science 2007 315 5812 659 663 2-s2.0-33846817351 10.1126/science.1135380 (Pubitemid 46214712)
71. Giorgio M., Migliaccio E., Orsini F., Paolucci D., Moroni M., Contursi C., Pelliccia G., Luzi L., Minucci S., Marcaccio M., Pinton P., Rizzuto R., Bernardi P., Paolucci F., Pelicci P. G., Electron transfer between cytochrome c and p 66 S h c generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005 122 2 221 233 2-s2.0-22744447211 10.1016/j.cell.2005.05.011 (Pubitemid 41032986)
72. Pinton P., Rizzuto R., P 66 S h c, oxidative stress and aging: importing a lifespan determinant into mitochondria. Cell Cycle 2008 7 3 304 308 2-s2.0-40549146557 (Pubitemid 351366492)
73. Rimessi A., Rizzuto R., Pinton P., Differential recruitment of PKC isoforms in HeLa cells during redox stress. Cell Stress and Chaperones 2007 12 4 291 298 2-s2.0-40749152802 10.1379/CSC-211.1
74. 2 induced p 66 S h c phosphorylation by ASK1-JNK inactivation in endothelium. Heart and Vessels 2007 22 6 423 427 2-s2.0-36749085223 10.1007/s00380-007-0994-9 (Pubitemid 350201440)
75. Yannoni Y. M., Gaestel M., Lin L., P 66 S h cA interacts with MAPKAP kinase 2 and regulates its activity. FEBS Letters 2004 564 1-2 205 211 2-s2.0-1842850620 10.1016/S0014-5793(04)00351-5 (Pubitemid 38490725)
76. Francia P., delli Gatti C., Bachschmid M., Martin-Padura I., Savoia C., Migliaccio E., Pelicci P. G., Schiavoni M., Lüscher T. F., Volpe M., Cosentino F., Deletion of p 66 S h c gene protects against age-related endothelial dysfunction. Circulation 2004 110 18 2889 2895 2-s2.0-8144229685 10.1161/01.CIR.0000147731.24444.4D (Pubitemid 39473614)
77. Trinei M., Giorgio M., Cicalese A., Barozzi S., Ventura A., Migliaccio E., Milia E., Padura I. M., Raker V. A., Maccarana M., Petronilli V., Minucci S., Bernardi P., Lanfrancone L., Pelicci P. G., A p53- p 66 S h c signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 2002 21 24 3872 3878 2-s2.0-0037198634 10.1038/sj/onc/1205513 (Pubitemid 34620855)
78. Napoli C., Martin-Padura I., de Nigris F., Giorgio M., Mansueto G., Somma P., Condorelli M., Sica G., de Rosa G., Pelicci P., Deletion of the p 66 S h c longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proceedings of the National Academy of Sciences of the United States of America 2003 100 4 2112 2116 2-s2.0-0037452461 10.1073/pnas.0336359100 (Pubitemid 36254582)
79. Graiani G., Lagrasta C., Migliaccio E., Spillmann F., Meloni M., Madeddu P., Quaini F., Padura I. M., Lanfrancone L., Pelicci P., Emanueli C., Genetic deletion of the p 66 S h c adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension 2005 46 2 433 440 2-s2.0-23244434000 10.1161/01.HYP.0000174986.73346.ba (Pubitemid 41099181)
80. Koch O. R., Fusco S., Ranieri S. C., Maulucci G., Palozza P., Larocca L. M., Cravero A. A. M., Farre' S. M., de Spirito M., Galeotti T., Pani G., Role of the life span determinant p 66 S h cA in ethanol-induced liver damage. Laboratory Investigation 2008 88 7 750 760 2-s2.0-46049112899 10.1038/labinvest.2008.44 (Pubitemid 351896640)
81. Zaccagnini G., Martelli F., Fasanaro P., Magenta A., Gaetano C., Di Carlo A., Biglioli P., Giorgio M., Martin-Padura I., Pelicci P. G., Capogrossi M. C., P 66 S h cA modulates tissue response to hindlimb ischemia. Circulation 2004 109 23 2917 2923 2-s2.0-16544365687 10.1161/01.CIR.0000129309.58874.0F (Pubitemid 38780308)
82. Zaccagnini G., Martelli F., Magenta A., Cencioni C., Fasanaro P., Nicoletti C., Biglioli P., Pelicci P. G., Capogrossi M. C., P 66 S h cA and oxidative stress modulate myogenic differentiation and skeletal muscle regeneration after hind limb ischemia. The Journal of Biological Chemistry 2007 282 43 31453 31459 2-s2.0-35748954925 10.1074/jbc.M702511200 (Pubitemid 350044897)
83. Franzeck F. C., Hof D., Spescha R. D., Hasun M., Akhmedov A., Steffel J., Shi Y., Cosentino F., Tanner F. C., von Eckardstein A., Maier W., Lüscher T. F., Wyss C. A., Camici G. G., Expression of the aging gene p 66 S h c is increased in peripheral blood monocytes of patients with acute coronary syndrome but not with stable coronary artery disease. Atherosclerosis 2012 220 1 282 286 2-s2.0-84155165596 10.1016/j.atherosclerosis.2011.10.035
84. Camici G. G., Schiavoni M., Francia P., Bachschmid M., Martin-Padura I., Hersberger M., Tanner F. C., Pelicci P., Volpe M., Anversa P., Lüscher T. F., Cosentino F., Genetic deletion of p 66 S h c adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 2007 104 12 5217 5222 2-s2.0-34247596394 10.1073/pnas.0609656104 (Pubitemid 47186202)
85. Kim G. H., Ryan J. J., Archer S. L., The role of redox signaling in epigenetics and cardiovascular disease. Antioxidants and Redox Signaling 2013 18 15 1920 1936
86. Malhotra A., Vashistha H., Yadav V. S., Dube M. G., Kalra S. P., Abdellatif M., Meggs L. G., Inhibition of p 66 S h cA redox activity in cardiac muscle cells attenuates hyperglycemia-induced oxidative stress and apoptosis. American Journal of Physiology-Heart and Circulatory Physiology 2009 296 2 H380 H388 2-s2.0-61949427618 10.1152/ajpheart.00225.2008
87. Ahmed N., Advanced glycation endproducts: role in pathology of diabetic complications. Diabetes Research and Clinical Practice 2005 67 1 3 21 2-s2.0-11144324314 10.1016/j.diabres.2004.09.004 (Pubitemid 40037725)
88. Schleicher E., Friess U., Oxidative stress, AGE, and atherosclerosis. Kidney International 2007 72 106 S17 S26 2-s2.0-34547447707 10.1038/sj.ki. 5002382 (Pubitemid 47172557)
89. Cai W., He J. C., Zhu L., Chen X., Striker G. E., Vlassara H., AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p 66 S h c -dependent FKHRL1 phosphorylation. American Journal of Physiology-Cell Physiology 2008 294 1 C145 C152 2-s2.0-38349191034 10.1152/ajpcell.00350.2007
90. Chintapalli J., Yang S., Opawumi D., Goyal S. R., Shamsuddin N., Malhotra A., Reiss K., Meggs L. G., Inhibition of wild-type p 66 S h cA in mesangial cells prevents glycooxidant-dependent FOXO3a regulation and promotes the survival phenotype. American Journal of Physiology-Renal Physiology 2007 292 2 F523 F530 2-s2.0-33846870605 10.1152/ajprenal.00215.2006 (Pubitemid 46220518)
91. Lam E. W.-F., Francis R. E., Petkovic M., FOXO transcription factors: key regulators of cell fate. Biochemical Society Transactions 2006 34 5 722 726 2-s2.0-33751296789 10.1042/BST0340722 (Pubitemid 44796405)
92. Purdom S., Chen Q. M., Linking oxidative stress and genetics of aging with p 66 S h c signaling and forkhead transcription factors. Biogerontology 2003 4 4 181 191 2-s2.0-0041885207 10.1023/A:1025123413403 (Pubitemid 37098457)
93. Pani G., Koch O. R., Galeotti T., The p53- p 66 S h c -Manganese Superoxide Dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species. International Journal of Biochemistry and Cell Biology 2009 41 5 1002 1005 2-s2.0-59849108790 10.1016/j.biocel.2008.10.011
94. Yamamori T., White A. R., Mattagajasingh I., Khanday F. A., Haile A., Qi B., Byeong H. J., Bugayenko A., Kasuno K., Berkowitz D. E., Irani K., P 66 S h c regulates endothelial NO production and endothelium-dependent vasorelaxation: implications for age-associated vascular dysfunction. Journal of Molecular and Cellular Cardiology 2005 39 6 992 995 2-s2.0-27644570778 10.1016/j.yjmcc.2005. 09.003 (Pubitemid 41572332)
95. Menini S., Iacobini C., Ricci C., Oddi G., Pesce C., Pugliese F., Block K., Abboud H. E., Giorgio M., Migliaccio E., Pelicci P. G., Pugliese G., Ablation of the gene encoding p 66 S h c protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation. Diabetologia 2007 50 9 1997 2007 2-s2.0-34547659642 10.1007/s00125-007-0728-7 (Pubitemid 47222849)
96. Natalicchio A., Laviola L., de Tullio C., Renna L. A., Montrone C., Perrini S., Valenti G., Procino G., Svelto M., Giorgino F., Role of the p 66 S h c isoform in insulin-like growth factor I receptor signaling through MEK/Erk and regulation of actin cytoskeleton in rat myoblasts. The Journal of Biological Chemistry 2004 279 42 43900 43909 2-s2.0-6344287822 10.1074/jbc.M403936200 (Pubitemid 39390698)
97. Natalicchio A., de Stefano F., Perrini S., Laviola L., Cignarelli A., Caccioppoli C., Quagliara A., Melchiorre M., Leonardini A., Conserva A., Giorgino F., Involvement of the p 66 S h c protein in glucose transport regulation in skeletal muscle myoblasts. American Journal of Physiology-Endocrinology and Metabolism 2009 296 2 E228 E237 2-s2.0-60849117798 10.1152/ajpendo.90347.2008
98. Pagnin E., Fadini G., de Toni R., Tiengo A., Calò L., Avogaro A., Diabetes induces p 66 S h c gene expression in human peripheral blood mononuclear cells: relationship to oxidative. Journal of Clinical Endocrinology and Metabolism 2005 90 2 1130 1136 2-s2.0-14044254273 10.1210/jc.2004-1283 (Pubitemid 40279244)
99. Thum T., Fraccarollo D., Schultheiss M., Froese S., Galuppo P., Widder J. D., Tsikas D., Ertl G., Bauersachs J., Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007 56 3 666 674 2-s2.0-33847346061 10.2337/db06-0699 (Pubitemid 46348461)
100. Di Stefano V., Cencioni C., Zaccagnini G., Magenta A., Capogrossi M. C., Martelli F., P 66 S h cA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose. Cardiovascular Research 2009 82 3 421 429 2-s2.0-66249112517 10.1093/cvr/cvp082
101. Napoli C., Witztum J. L., Calara F., de Nigris F., Palinski W., Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses. Circulation Research 2000 87 10 946 952 2-s2.0-0034634298
102. Napoli C., de Nigris F., Palinski W., Multiple role of reactive oxygen species in the arterial wall. Journal of Cellular Biochemistry 2001 82 4 674 682 2-s2.0-0034894990 10.1002/jcb.1198 (Pubitemid 32720682)
103. Napoli C., de Nigris F., Welch J. S., Calara F. B., Stuart R. O., Glass C. K., Palinski W., Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation 2002 105 11 1360 1367 2-s2.0-0037133683 10.1161/hc1102.106792 (Pubitemid 34260429)
104. Boullier A., Bird D. A., Chang M., Dennis E. A., Friedman P., Gillotte-Taylor K., Hörkkö S., Palinski W., Quehenberger O., Shaw P., Steinberg D., Terpstra V., Witztum J. L., Scavenger receptors, oxidized LDL, and atherosclerosis. Annals of the New York Academy of Sciences 2001 947 214 223 2-s2.0-18244363912 (Pubitemid 34059916)
105. Bosutti A., Grassi G., Zanetti M., Aleksova A., Zecchin M., Sinagra G., Biolo G., Guarnieri G., Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66(ShcA) in pacemaker-implanted patients. Clinical and Experimental Medicine 2007 7 1 16 23 2-s2.0-33947525740 10.1007/s10238-007- 0118-y (Pubitemid 46475004)
106. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., Komuro I., Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002 105 13 1541 1544 2-s2.0-0037007075 10.1161/01.CIR.0000013836.85741.17 (Pubitemid 34297628)
107. Brodsky S. V., Gealekman O., Chen J., Zhang F., Togashi N., Crabtree M., Gross S. S., Nasjletti A., Goligorsky M. S., Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circulation Research 2004 94 3 377 384 2-s2.0-1242275127 10.1161/01.RES.0000111802.09964.EF (Pubitemid 38240730)
108. Matsui-Hirai H., Hayashi T., Yamamoto S., Ina K., Maeda M., Kotani H., Iguchi A., Ignarro L. J., Hattori Y., Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide. Journal of Pharmacology and Experimental Therapeutics 2011 337 3 591 599 2-s2.0-79956216700 10.1124/jpet.110.177584
109. Colman R. J., Anderson R. M., Johnson S. C., Kastman E. K., Kosmatka K. J., Beasley T. M., Allison D. B., Cruzen C., Simmons H. A., Kemnitz J. W., Weindruch R., Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009 325 5937 201 204 2-s2.0-67650439330 10.1126/science. 1173635
110. Rogina B., Helfand S. L., Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proceedings of the National Academy of Sciences of the United States of America 2004 101 45 15998 16003 2-s2.0-8644224064 10.1073/pnas.0404184101 (Pubitemid 39507916)
111. Potente M., Dimmeler S., Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle 2008 7 14 2117 2122 2-s2.0-47849088748 (Pubitemid 352036236)
112. Zhou S., Chen H., Wan Y., Zhang Q., Wei Y., Huang S., Liu J., Lu Y., Zhang Z., Yang R., Zhang R., Cai H., Liu D., Liang C., Repression of p 66 S h c expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circulation Research 2011 109 6 639 648 2-s2.0-80052580047 10.1161/CIRCRESAHA.111.243592
113. Alcendor R. R., Gao S., Zhai P., Zablocki D., Holle E., Yu X., Tian B., Wagner T., Vatner S. F., Sadoshima J., Sirt1 regulates aging and resistance to oxidative stress in the heart. Circulation Research 2007 100 10 1512 1521 2-s2.0-34249669270 10.1161/01.RES.0000267723.65696.4a (Pubitemid 46834764)
114. Mattagajasingh I., Kim C., Naqvi A., Yamamori T., Hoffman T. A., Jung S., DeRicco J., Kasuno K., Irani K., SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences of the United States of America 2007 104 37 14855 14860 2-s2.0-35549008884 10.1073/pnas.0704329104 (Pubitemid 350003232)
115. Brunet A., Sweeney L. B., Sturgill J. F., Chua K. F., Greer P. L., Lin Y., Tran H., Ross S. E., Mostoslavsy R., Cohen H. Y., Hu L. S., Cheng H., Jedrychowski M. P., Gygi S. P., Sinclair D. A., Alt F. W., Greenberg M. E., Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004 303 5666 2011 2015 2-s2.0-12144290563 10.1126/science.1094637 (Pubitemid 38393275)
116. Luo J., Nikolaev A. Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., Gu W., Negative control of p53 by Sir2 α promotes cell survival under stress. Cell 2001 107 2 137 148 2-s2.0-0035913911 10.1016/S0092-8674(01)00524-4 (Pubitemid 33035941)
117. Chen H., Wan Y., Zhou S., Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence. Science China Life Sciences 2012 55 6 467 473
118. Reddy M. A., Jin W., Villeneuve L., Wang M., Lanting L., Todorov I., Kato M., Natarajan R., Pro-inflammatory role of MicroRNA-200 in vascular smooth muscle cells from diabetic mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 3 721 729 2-s2.0-84857653511 10.1161/ATVBAHA.111.241109
119. Brabletz S., Brabletz T., The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Reports 2010 11 9 670 677 2-s2.0-77956230322 10.1038/embor.2010.117
120. Magenta A., Cencioni C., Fasanaro P., Zaccagnini G., Greco S., Sarra-Ferraris G., Antonini A., Martelli F., Capogrossi M. C., MiR-200c is
121. Rosati J., Spallotta F., Nanni S., Grasselli A., Antonini A., Vincenti S., Presutti C., Colussi C., D'Angelo C., Biroccio A., Farsetti A., Capogrossi M. C., Illi B., Gaetano C., Smad-interacting protein-1 and microRNA 200 family define a nitric oxide-dependent molecular circuitry involved in embryonic stem cell mesendoderm differentiation. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 4 898 907 2-s2.0-79953744099 10.1161/ATVBAHA.110.214478
122. Villeneuve L. M., Kato M., Reddy M. A., Wang M., Lanting L., Natarajan R., Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 2010 59 11 2904 2915 2-s2.0-78049294740 10.2337/db10-0208
123. Manca S., Magrelli A., Cialfi S., Lefort K., Ambra R., Alimandi M., Biolcati G., Uccelletti D., Palleschi C., Screpanti I., Candi E., Melino G., Salvatore M., Taruscio D., Talora C., Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation. Experimental Dermatology 2011 20 11 932 937 2-s2.0-80054118982 10.1111/j.1600-0625.2011.01359.x
124. Wang J. M., Tao J., Chen D. D., MicroRNA miR-27b rescues bone Marrow-Derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus. Arteriosclerosis, Thrombosis, and Vascular Biology 2014 34 1 99 109
125. Fasanaro P., D'Alessandra Y., Di Stefano V., Melchionna R., Romani S., Pompilio G., Capogrossi M. C., Martelli F., MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3. The Journal of Biological Chemistry 2008 283 23 15878 15883 2-s2.0-47049119934 10.1074/jbc.M800731200
126. Zaccagnini G., Maimone B., Di Stefano V., Hypoxia-induced miR-210 modulates tissue response to acute peripheral ischemia. Antioxid Redox Signal 2013 10.1089/ars.2013.5206
127. Greco S., Fasanaro P., Castelvecchio S., MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes 2012 61 6 1633 1641
128. Li Y., Reddy M. A., Miao F., Shanmugam N., Yee J., Hawkins D., Ren B., Natarajan R., Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF- B-dependent inflammatory genes: relevance to diabetes and inflammation. The Journal of Biological Chemistry 2008 283 39 26771 26781 2-s2.0-55549140173 10.1074/jbc.M802800200
129. El-Osta A., Brasacchio D., Yao D., Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. Journal of Experimental Medicine 2008 205 10 2409 2417
130. Candido R., Jandeleit-Dahm K. A., Cao Z., Nesteroff S. P., Burns W. C., Twigg S. M., Dilley R. J., Cooper M. E., Allen T. J., Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 2002 106 2 246 253 2-s2.0-0037047082 10.1161/01.CIR.0000021122.63813.32 (Pubitemid 34761307)
131. Candido R., Allen T. J., Lassila M., Cao Z., Thallas V., Cooper M. E., Jandeleit-Dahm K. A., Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 2004 109 12 1536 1542 2-s2.0-1842538570 10.1161/01.CIR.0000124061.78478.94 (Pubitemid 38420183)
132. Kerr D. S., Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade. Molecular Genetics and Metabolism 2010 99 3 246 255 2-s2.0-76349123010 10.1016/j.ymgme.2009.11.005
133. Paneni F., Mocharla P., Akhmedov A., Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes. Circulation Research 2012 111 3 278 289
134. Kim Y. R., Kim C. S., Naqvi A., Epigenetic upregulation of p 66 S h c mediates low-density lipoprotein cholesterol-induced endothelial cell dysfunction. American Journal of Physiology-Heart and Circulatory Physiology 2012 303 2 H189 H196
135. Münzel T., Gori T., Bruno R. M., Taddei S., Is oxidative stress a therapeutic target in cardiovascular disease? European Heart Journal 2010 31 22 2741 2748 2-s2.0-78649357316
136. Stephens N. G., Parsons A., Schofield P. M., Kelly F., Cheeseman K., Mitchinson M. J., Brown M. J., Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). The Lancet 1996 347 9004 781 786 2-s2.0-0029925181 10.1016/S0140-6736(96)90866-1 (Pubitemid 26091640)
137. Salonen R. M., Nyyssönen K., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Rissanen T. H., Tuomainen T., Valkonen V., Ristonmaa U., Lakka H., Vanharanta M., Salonen J. T., Poulsen H. E., Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the antioxidant supplementation in atherosclerosis prevention (ASAP) study. Circulation 2003 107 7 947 953 2-s2.0-0037465430 10.1161/01.CIR.0000050626.25057.51 (Pubitemid 36258715)
138. Kris-Etherton P. M., Lichtenstein A. H., Howard B. V., Steinberg D., Witztum J. L., Antioxidant vitamin supplements and cardiovascular disease. Circulation 2004 110 5 637 641 2-s2.0-3543062356 10.1161/01.CIR.0000137822. 39831.F1 (Pubitemid 39031177)
139. Sesso H. D., Buring J. E., Christen W. G., Kurth T., Belanger C., MacFadyen J., Bubes V., Manson J. E., Glynn R. J., Gaziano J. M., Vitamins E and C in the prevention of cardiovascular disease in men: the physicians' health study II randomized controlled trial. Journal of the American Medical Association 2008 300 18 2123 2133 2-s2.0-56149111693 10.1001/jama.2008.600
140. Bjelakovic G., Nikolova D., Gluud L. L., Simonetti R. G., Gluud C., Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Journal of the American Medical Association 2007 297 8 842 857 2-s2.0-33847378451 10.1001/jama.297.8.842 (Pubitemid 46333949)
141. Stoclet J., Chataigneau T., Ndiaye M., Oak M., El Bedoui J., Chataigneau M., Schini-Kerth V. B., Vascular protection by dietary polyphenols. European Journal of Pharmacology 2004 500 1-3 299 313 2-s2.0-4644302860 10.1016/j.ejphar.2004.07.034 (Pubitemid 39304017)
142. Hooper L., Kroon P. A., Rimm E. B., Cohn J. S., Harvey I., Le Cornu K. A., Ryder J. J., Hall W. L., Cassidy A., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition 2008 88 1 38 50 2-s2.0-46649098436 (Pubitemid 351988681)
143. Szkudelski T., Resveratrol-induced inhibition of insulin secretion from rat pancreatic islets: evidence for pivotal role of metabolic disturbances. American Journal of Physiology-Endocrinology and Metabolism 2007 293 4 E901 E907 2-s2.0-35148897270 10.1152/ajpendo.00564.2006 (Pubitemid 47535820)
144. Szkudelski T., Szkudelska K., Anti-diabetic effects of resveratrol. Annals of the New York Academy of Sciences 2011 1215 1 34 39 2-s2.0-78851469053 10.1111/j.1749-6632.2010.05844.x
145. Palsamy P., Subramanian S., Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic β -cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. Journal of Cellular Physiology 2010 224 2 423 432 2-s2.0-77953644361 10.1002/jcp.22138
146. Ghanim H., Sia C. L., Korzeniewski K., Lohano T., Abuaysheh S., Marumganti A., Chaudhuri A., Dandona P., A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. Journal of Clinical Endocrinology and Metabolism 2011 96 5 1409 1414 2-s2.0-79955675928 10.1210/jc.2010-1812
147. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 α Cell 2006 127 6 1109 1122 2-s2.0-33845399894 10.1016/j.cell.2006.11.013 (Pubitemid 44894520)
148. Timmers S., Hesselink M. K., Schrauwen P., Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits? Annals of the New York Academy of Sciences 2013 1290 83 89
149. Williams H. C., Griendling K. K., NADPH oxidase inhibitors: new antihypertensive agents? Journal of Cardiovascular Pharmacology 2007 50 1 9 16 2-s2.0-34547652582 10.1097/FJC.0b013e318063e820 (Pubitemid 47220441)
150. Cangemi R., Loffredo L., Carnevale R., Perri L., Patrizi M. P., Sanguigni V., Pignatelli P., Violi F., Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E. European Heart Journal 2008 29 1 54 62 2-s2.0-38049004028 10.1093/eurheartj/ehm565
151. John S., Delles C., Jacobi J., Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks. Journal of the American College of Cardiology 2001 37 5 1351 1358
152. Friedl H. P., Smith D. J., Till G. O., Thomson P. D., Louis D. S., Ward P. A., Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity. The American Journal of Pathology 1990 136 3 491 495 2-s2.0-0025214271 (Pubitemid 20105914)
153. Butler R., Morris A. D., Belch J. J. F., Hill A., Struthers A. D., Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000 35 3 746 751 2-s2.0-0034065857 (Pubitemid 30165320)
154. Gori T., Parker J. D., Nitrate-induced toxicity and preconditioning: a rationale for reconsidering the use of these drugs. Journal of the American College of Cardiology 2008 52 4 251 254 2-s2.0-46849092968 10.1016/j.jacc.2008. 04.019 (Pubitemid 351957846)
155. Steinhubl S. R., Why have antioxidants failed in clinical trials? American Journal of Cardiology 2008 101 10 14D 19D 2-s2.0-43049180323 10.1016/j.amjcard.2008.02.003